RobertWHollowayMDFACOG, FACS

PubMed

• Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA ...
  Mutch, D., Voulgari, A., Chen, X., Oaknin, A., Perez Fidalgo, J., Montosa, F., Herraez, A., Powell, M., Nowicka, M., Schaefer, G., Merchant, M., Yan, Y., Bradley, W., ...> ;Cancer. 2024 Jan 30
• Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
  Fernando Recio, Carly Bess Scalise, Paul Loar, Melissa Lumish, Tara Berman, Abhinand Peddada, Ekaterina Kalashnikova, Samuel Rivero-Hinojosa, Tricia Beisch, Brittany N...> ;Gynecologic Oncology. 2024 Mar 1
• Standardized Titration Protocol Reduces the Incidence of Paclitaxel Infusion-Related Hypersensitivity Reactions.
  Kofi Sefah, Karolina A Kilowski, Sarah A Gifford, Angela Grove, Jon Shaffer, Baylee Bryan, Sarfraz Ahmad, Robert W Holloway> ;JCO Oncology Practice. 2023 Dec 1
• Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation.
  Nathalie D McKenzie, Sarfraz Ahmad, Ahmad Awada, Theresa M Kuhn, Fernando O Recio, Robert W Holloway> ;Life Sciences. 2023 Nov 15
• 1 citations
  A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...
  Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
• Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer.
  Nnamdi I Gwacham, Karolina A Kilowski, Fernando O Recio, Ahmad Awada, Theresa M Kuhn, Jianbin Zhu, Ameya Patel, Sarfraz Ahmad, Nathalie D McKenzie, James E Kendrick, R...> ;Gynecologic Oncology. 2023 Aug 1
• 1 citations
  Ganglioneuroblastoma arising in a Mature Cystic Teratoma of Ovary: Report and Literature review of an uncommon neoplasm.
  Nikita Shah, Karolina Kilowski, Robert Holloway, Charanjeet Singh> ;Gynecologic Oncology Reports. 2022 Dec 1
• 2 citations
  Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.
  Sarah A Ackroyd, David Arguello, Pilar Ramos, Haider Mahdi, Adam ElNaggar, Ira Winer, Rob Holloway, Thomas Krivak, Nathaniel Jones, Valerie Galvan Turner, Thomas Herzo...> ;Gynecologic Oncology. 2023 Feb 1
• 12 citations
  Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma.
  David M O'Malley, Amit M Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I Weberpals, Andrew R Clamp, Giovanni Scambia, Al...> ;Gynecologic Oncology. 2022 Dec 1
• 8 citations
  Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.
  Adam ElNaggar, David Robins, Yasmine Baca, David Arguello, Michael Ulm, Rebecca Arend, Gina Mantia-Smaldone, Christina Chu, Ira Winer, Rob Holloway, Tom Krivak, Nathan...> ;Gynecologic Oncology. 2022 Nov 1
• 11 citations
  The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis.
  Lara C Burg, Shenna Verheijen, Ruud L M Bekkers, Joanna IntHout, Robert W Holloway, Salih Taskin, Sarah E Ferguson, Yu Xue, Antonino Ditto, Glauco Baiocchi, Andrea Pap...> ;Journal of Gynecologic Oncology. 2022 Sep 1
• Corrigendum to "A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer" [Gynecologic Oncology 163 (2021) ...
  Madhavi Manyam, Amanda J Stephens, Jessica A Kennard, Jane LeBlanc, Sarfraz Ahmad, James E Kendrick, Robert W Holloway> ;Gynecologic Oncology. 2022 May 1
• 1 citations
  Multidisciplinary approach to pelvic leiomyomatosis with intracaval and intracardiac extension: A case report and review of the literature.
  Nnamdi I Gwacham, Madhavi Manyam, Christine K Fitzsimmons, Karolina A Kilowski, David Varnagy, Tomer Z Karas, Robert W Holloway> ;Gynecologic Oncology Reports. 2022 Apr 1
• 5 citations
  Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives.
  Ahmad Awada, Sarfraz Ahmad, Nathalie D McKenzie, Robert W Holloway> ;Oncotargets and Therapy. 2022 Jan 1
• ASO Visual Abstract: Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy-Recurrence Patterns, Risk Factors, and Survival.
  Christine K. Fitzsimmons, Amanda J. Stephens, Jessica A. Kennard, Madhavi Manyam, Julie Pepe, Sarfraz Ahmad, Nathalie D. McKenzie, James E. Kendrick, Robert W. Holloway> ;Annals of Surgical Oncology. 2021 Nov 30
• 2 citations
  Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy: Recurrence Patterns, Risk Factors, and Survival.
  Christine K. Fitzsimmons, Amanda J. Stephens, Jessica A. Kennard, Madhavi Manyam, Julie Pepe, Sarfraz Ahmad, Nathalie D. McKenzie, James E. Kendrick, Robert W. Holloway> ;Annals of Surgical Oncology. 2021 Nov 10
• 9 citations
  Assessment of immune biomarkers and establishing a triple negative phenotype in gynecologic cancers.
  G. Contos, Yasmine Baca, Joanne Xiu, Jennifer Brown, Robert W. Holloway, W.M. Korn, Thomas J. Herzog, N.L. Jones, Ira Winer> ;Gynecologic Oncology. 2021 Nov 1
• 14 citations
  A phase 1b study of intraperitoneal oncolytic viral immunotherapy in platinum-resistant or refractory ovarian cancer.
  Madhavi Manyam, Amanda J. Stephens, Jessica A. Kennard, Jane LeBlanc, Sarfraz Ahmad, James E. Kendrick, Robert W. Holloway> ;Gynecologic Oncology. 2021 Oct 20
• 3 citations
  Predicted Immunogenicity of CDK12 Biallelic Loss-of-Function Tumors Varies across Cancer Types.
  Andrew Elliott, Jian Zhang, Qing Zhang, Jeffrey Swensen, Daniel Martin, Joanne Xiu, Daniel M. Geynisman, Daniel A. Vaena, Thomas J. Herzog, Robert W. Holloway, Wafik S...> ;The Journal of Molecular Diagnostics. 2021 Sep 22
• 3 citations
  Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen...
  , , , , , , , , , , , , , , , , , , , , , , > ;Cancer Medicine. 2021 Sep 21
• 6 citations
  Rucaparib maintenance treatment for recurrent ovarian carcinoma: The effects of progression-free interval and prior therapies on efficacy and safety in the randomized ...
  , , , , , , , , , , , , , , , , , , , , , > ;International Journal of Gynecological Cancer. 2021 Jul 1
• 1 citations
  Intratubal Pseudopapillary Histiocytic Hyperplasia: A New Histologic Variant in the Spectrum of Histiocytic Lesions Involving the Fallopian Tube.
  Tien Anh N. Tran, Robert W. Holloway> ;International Journal of Gynecological Pathology. 2021 Jul 1
• 12 citations
  Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2–4 cm; emerging data and future perspectives
  Nnamdi I. Gwacham, N McKenzie, Evan R. Fitzgerald, Sarfraz Ahmad, Robert W. Holloway> ;Gynecologic Oncology. 2021 Jun 12
• 35 citations
  Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics
  Zibi Marchocki, Maria C. Cusimano, Lauren Clarfield, Soyoun Rachel Kim, Rouhi Fazelzad, Osvaldo Espin-Garcia, Genevieve Bouchard-Fortier, Emma C. Rossi, Katherine Stew...> ;American Journal of Obstetrics and Gynecology. 2021 May 28
• 9 citations
  The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
  Nathalie D. McKenzie, Hannah Hong, Sarfraz Ahmad, Robert W. Holloway> ;Critical Reviews in Oncology/hematology. 2021 Jan 1
• Join now to see all

Journal Articles

• Two Classes of Cyclic AMP Binding Sites of Type II Protein Kinase Demonstrate Synergism When Added Together to Intact Adipocytes.  
  Beebe S; Holloway RW; Rannels SR; Corbin JD, J. Biol. Chem., 256:6
• Cefotan versus Cefoxitin as Prophylaxis in Hysterectomy.  
  Orr JW; Varner RE; Kilgore LC; McDiramid M; Holloway RW, Am. J. Obstet. Gynecol. 154:960-3
• Psammoma Bodies in Cervicovaginal Smear Associated with an Intrauterine Device.  
  Barter JF; Orr JW; Holloway RW; Hatch KD; Shingleton HM, J. Reprod. Med. 32:147-8
• Surgical Staging of Uterine Cancer. An analysis of perioperative morbidity.  
  Orr JW; Holloway RW; Orr PF; Holimon JL, Gynecol. Oncol. 42: 209-216
• Radiotherapy of Malignant Subdiaphragmatic Implants in Advanced Ovarian Carcinoma: A New Technique.  
  Pirkowski M; Holloway RW; Delgado G; Barnes W; Thomas D; Torrisi J; Popescu G; Rogers J; Dritchilo A, Int. J. Radiat. Oncol. Biol. Phys. 22: 1105-1108
• An Evaluation of Groshong Central Venous Catheters on a Gynecologic Oncology Service.  
  Holloway RW; Orr JW, Gynecol. Oncol. 56: 211-217
• Phase II Trial of Topotecan Combined with Cisplatin in Squamous and Non-Squamous Cervical Cancer, Preliminary Results.  
  Fiorica J; Grendys E; Holloway RW; Orr JW; Ndubisi B; DeCesare S; LaPolla J; Boothby R; Hoffman M; Arrango H, Gynecol. Oncol. 1441
• A Phase II Study to Determine the Efficacy and Tolerability of Intravenous ZD9331 in Heavily Pre-Treated Patients with Ovarian Cancer.  
  Rader JS; Clarke-Pearson D; Moore M; Carson L; Holloway RW; Kao MS; Wiznitzer I; Douglass EC, Gynecol. Oncol. 91:318-325
• Clinical-Pathologic and Morbidity Analyses of Types 2 and 3 Abdominal Radical Hysterectomy for Cervical Cancer.  
  Pikaart, DP; Holloway RW; Ahmad S; Finkler NJ; Bigsby IV GE; Ortiz BH; DeNardis SA, Gynecol. Oncol. 107: 205-210
• Metastatic Appendiceal Mucinous Adenocarcinoma to Well-Differentiated Diffuse Mesothelioma of the Peritoneal Cavity: A Mimicker of Florid Mesothelial Hyperplasia in As...  
  Tran T; Holloway RW; Finkler NJ, Int. J. Gynecol. Pathol. 27: 526-530
• Functional characterization of a fluorescent highly tumorigenic ovarian cancer cell line to test cellular therapy in experimental models.  
  Ingersoll SB, Ahmad S, Stoltzfus GP, Patel S, Radi MJ, Finkler NJ, Edwards JR, Holloway RW, Int. J. Gynecol. Cancer 2011; 21: 457-465
• Chemoradiation with adjuvant hysterectomy for stage IB-2 cervical cancer: 10 year experince.  
  Bigsby IV GE, Holloway RW, Ahmad S, Sombeck MD, Ebra G, Finkler NJ, Gynecol. Surg. 2011; [DPI: 10.1007/s10397-011-0717-1]
• Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery.  
  Brudie LA, Gaia G, Ahmad S, Finkler NJ, Bigsby IV GE, Ghurani GB, Kendrick IV JE, Rakowski JA, Groton JH, Holloway RW, J. Robotic Surg. 2011; 6
• Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.  
  Turkson J, Oncogene 2012; 31: 2309-2322
• Short- and long-term complications and morbidity of robotic-assisted comprehensive endometrial cancer staging.  
  Backes FJ, Brudie LA, Farrell MR, Ahmad S, Finkler NJ, Bigsby GE, O’Malley D, Cohn DE, Holloway RW, Fowler JM, Gynecol. Oncol. 2012; 125: 546-551
• Operative outcomes and complications: Robotic versus abdominal hysterectomy for complex benign cases.  
  Beilan JA, Boardman LA, Johnson TR, Ahmad S, Bigsby GE, Finkler NJ, Holloway RW, Obstet. Gynecol
• Join now to see all

Books/Book Chapters

• Textbook of Gynecology. 
  Chapter: Intraoperative Techniques in Gynecologic Survey 
  Orr Jr JW and Holloway RWEditors: Copeland L.WB Saunders Company
• Textbook of Gynecology. 
  Chapter: Postoperative Care in Gynecologic Surgery 
  Orr Jr. JW and Holloway RWEditors: Copeland L.WB Saunders Company
• Gynecology and Obstetrics: A Longitudinal Approach. 
  Chapter: Perioperative Care 
  Page 741 - 752Orr Jr JW and Holloway RWEditors: Moore, Reiter, Rebar & Baker.Churchill Livingstone, Inc
• Gynecology and Obstetrics: A Longitudinal Approach. 
  Chapter: Neoplasia in Pregnancy 
  Page 385 - 395Orr Jr JW, Barrett JR, and Holloway RWEditors: Moore, Reiter, Rebar and Baker.Churchill Livingstone, Inc
• Proceedings of the 4th Annual Meeting of SERGS. 
  Chapter: Standardization of one approach to robotic-assisted pelvic and aortic lymphadenectomy for patients with endometrial cancer including the morbidly obese 
  Page 35 - 43Holloway RW, Ahmad SEditors: Lambaudie E, Narducci F.Marseille, France
• Robotic Gynecologic Surgery. 
  Chapter: Robotic pelvic and aortic lymphadenectomy for gynecologic malignancies – One approach 
  Kendrick JE IV, Ahmad S, Holloway RWEditors: Kilic SG, Ertan K, Kose F.European PublisherEdition 1,
• Join now to see all

Abstracts/Posters

• Comparison of Loss of Heterozygosity of 3p and Cytogenesis between Ovarian Tumors of Low Malignant Potential and Malignant Ovarian Tumors.
  Crawford, EC; Orr Jr JW; Holloway RW; Futrell P, et al, American Journal of Human Genetics Vol.53 (3): Abstract #28, Supplement
• Experience with the Groshong Catheter on a Gynecologic Oncology Service.
  Holloway RW and Orr, Jr. JW, The Felix Rutledge Society, Padua, Italy
• Experience with the Groshong Catheter on a Gynecologic Oncology Service.
  Holloway RW and Orr Jr., JW, American College of Obstetrics & Gynecology (ACOG) Annual Meeting, Orlando, Florida
• Ovarian Cancer Patients with In Vitro Resistance to Platinum Exhibit Poorer Survival After Treatment with Platinum Based Chemotherapy.
  Mehta RS; Parker RJ; Fruehauf JP; Finkler NJ; Holloway RW, American Association Cancer Research, San Francisco, CA
• Phase II Trial of ZD9331 as Third-Line Therapy for Patients with Ovarian Carcinoma.
  Rader J; Clarke-Pearson D; Moore M; Carson L; Holloway RW; Kao M-S; Wiznitzer I; Douglass E, European Society of Medical Oncology
• Phase II Evaluation of OSI-774, A Potent Oral Antagonist of the EGFR-TK in Patients with Advanced Ovarian Carcinoma.
  Holloway RW and Finkler NJ, American Society of Clinical Oncology, ASCO Mascone Center, San Francisco, CA
• A Phase I/II Trial of Weekly Topotecan in the Treatment of Advanced Recurrent Metastatic Endometrial Carcinoma.
  Holloway, RW, 38th Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida
• Doxil and Gemcitabine Combination Therapy for Recurrent Ovarian Cancer, Results of a Phase II trial.
  Holloway RW; Finkler NJ; Nye L; Bigsby IV GE; Ortiz BH, American Society of Clinical Oncology Annual Conference
• Combination Chemoradiation Followed by Simple Hysterectomy for Treatment of IB-2 Cervical Cancer.
  Bigsby IV GE; Holloway RW; Finkler NJ; Ortiz BH; Sombeck MD, Poster Presentation SGO
• Phase II Trial of Single-Agent Cetuximab in Patients with Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma with the Potential for Dose Escala...
  Schilder RJ; Lokshin AE; Holloway RW; Alvarez RD; Pathak H; Aghajanian C; Drescher CW; Godwin AK, American Society of Clinical Oncology
• A Phase II Trial of the mTOR Inhibitor AP23573 as a Single Agent in Advanced Endometrial Cancer.
  Colombo N; McMeekin S; Schwartz P; Kostka J; Sessa C; Gehrig P; Holloway R; Braly P; Matei D; Einstein M, American Society of Clinical Oncology
• Comparison of Robotic-Assisted Laparoscopic versus Total Abdominal Hysterectomy and Lymphadenectomy for Endometrial Cancer.
  DeNardis SA; Holloway RW; Bigsby IV GE; Pikaart DP; Ahmad S, Gynecol. Oncol. 108 (3, Suppl.1): A790, Finkler NJ
• The Association of ERCC1 and Clinical Outcomes of Women with Advanced Ovarian Cancer.
  Teoh D; Holloway RW; Cohen J; Gu M; Ricketts W; Hu JM; Shin JY; Powell CB; Chen L; Chan JK, Abstract No. 5575. J Clin Oncol 26, American Society of Clinical Oncology (ASCO) Annual Meeting
• Robotic-assisted Laparoscopic Hysterectomy with Lymphadenectomy for Endometrial Cancer: The learning curve and beyond
  Holloway RW; Ahmad S; DeNardis SA; Sultana N; Bigsby GE; Pikaart DP; Finkler NJ, Gynecol. Oncol. 2009; 112 (Suppl.1), A337
• Tolerability, Efficacy and Safety of Pegylated Liposomal Doxorubin in Combination with Carboplatin Versus Gemcitabine/Carboplatin for the Treatment of Platinum-sensiti...
  Holloway RW; Grendys EC; McMeekin S, Gynecol. Oncol. 2009; 112 (Suppl.1): A316
• Functional Characterization of Fluorescent Highly Tumorigenic Cell Line to use in an Animal Model of Ovarian Cancer.
  Ingersoll SB; Ahmad S; Patel S; Edwards D; Patel D; Caballero L; Holloway RW; Edwards JR, Gynecol. Oncol. 2009; 112 (Suppl.1): A208
• The use of Extreme Drug Resistance Assay in Predicting Success with Intraperitoneal Chemotherapy for Advanced Ovarian Cancer.
  Pant A; Diaz-Montes T; Tanner E: McCormick CC; Ahmad S; Giuntoli RL; Holloway RW; Bristow RE, Gynecol. Oncol. 2009; 112 (Suppl.1): A124
• Molecular Characterization of Highly Tumorigenic Cell Lines Used in a Xenograph Model to Investigate Cellular Therapy for the Treatment of Refractory Ovarian Cancer.
  Ingersoll SB, Yue P, Ahmad S, Turkson J, Edwards JR, Holloway RW, J. Clin. Oncol., 2009; 27 (Suppl.): e-16516
• The Florida Hospital 3-year experience with robotic surgery in gynecologic oncology.
  Holloway RW, Proc. 1st. Eur. Symp. Robotic Gynaecol. Surg, Milan, Italy
• Robotic-assisted surgery for early-stage ovarian and tubal malignancies.
  Holloway RW, Finkler NJ, Bigsby IV GE, McCollough B, Peterson LB, Rakowski JA, Ahmad S, Proc. 1st. Eur. Symp. Robotic Gynaecol. Surg, Milan, Italy
• BMI-controlled evaluation of clinico-pathological factors and surgical outcomes of patients with endometrial cancer: Robotic vs. open hysterectomy with lymphadenectomy.
  Holloway RW, Ahmad S, Sultana N, Bigsby IV GE, DeNardis SA, Peterson LB, Finkler NJ, Proc. 1st. Eur. Symp. Robotic Gynaecol. Surg, Milan, Italy
• Minimizing robotic-assisted laparoscopic hysterectomy: The 3-port technique.
  Holloway RW, Kendrick JE, Peterson LB, Proc. 1st. Eur. Symp. Robotic Gynaecol. Surg, Milan, Italy
• Analyses of factors associated with the performance of total abdominal versus robotic-assisted laparoscopic hysterectomy for endometrial cancer.
  Holloway RW, Ahmad S, Bigsby IV GE, Peterson LB, Ghurani GB, Lester M, Finkler NJ, Gynecol. Oncol. 2010; 116 (Supp.1): A209
• The role of adjuvant therapy in women with optimally cytoreduced stage IIIC endometrial cancer.
  Alvarez Secord A, Watson D, Holloway RW, Geller MA, Gehrig PA, O’Malley DM, Bae-Jump V, Cohn DE, Finkler NJ, Havrilesky LJ, Gynecol. Oncol. 2010; 116 (Supp.1): A202
• A multicenter, randomized, phase II study evaluating the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carbop...
  Alvarez Secord A, Berchuck A, Higgins R, Nucum L, Kohler M, Puls L, Holloway RW, Lewandowski G, Valea F, Havrilesky L, Gynecol. Oncol. 2010; 116 (Suppl. 1), A3
• Join now to see all

Lectures

• Phase 1b study of oncolytic vaccinia virus GL-ONC1 in recurrent ovarian cancer (ROC). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• Ovarian Cancer Update. 
  Home Therapy Nursing Society of Central Florida
• Colposcopy of the Female Lower Genital Tract. 
  University of Central Florida, Nurse Practitioner Organization
• Modern Evaluation and Management of the Adnexal Mass. 
  University of Minnesota
• Bedside Placement of the Groshong Catheter. 
  University of Minnesota
• Surgical Staging of Endometrial Cancer. 
  Florida Hospital/Waterman
• Update in Gynecology Oncology. 
  Florida Radiation Technician Annual Meeting
• Modern Therapy of Ovarian Cancer, Dose Intensity Issues. 
  AMGEN Corporation, Atlanta, Georgia
• Ovarian Cancer Management Issues. 
  Port Smith Naval Hospital, Port Smith, VA, 1997; Chesapeake General Hospital, Chesapeake, VA, 1997
• Surgical Staging of Endometrial Carcinoma. 
  Halifax Hospital, Daytona Beach Grand Rounds
• Management of Advanced Staged Cervical Cancer. 
  Holmes Regional Medical Center, Melbourne, FL
• Controversies in Management of Ovarian Cancer. 
  Halifax Medical Center, Daytona Beach, Grand Rounds
• Oophorectomy, Considerations for the General Surgeon. 
  American College of Surgeons, Annual Meeting, Orlando, FL
• Gynecologic Cancer Screening. 
  Seminole County Medical Society, Heathrow, FL
• Tamoxifen Clinical Trials. 
  Central Florida OB/GYN, Orlando, FL
• Ovarian Cancer Patients with In Vitro Resistance to Platinum. 
  Winter Meeting of the Society Gynecologic Oncologists, Salt Lake City, Utah
• Association Between In Vitro Platinum Resistance in the EDR Assay and Clinical Outcomes for Ovarian Cancer Patients. 
  Society of Gynecologic Oncologists, Nashville, TN
• Patients with Persistent/Recurrent Ovarian Cancer Should Receive a Regimen Chosen by an In-Vitro Assay. 
  Gynecologic Oncology Group, Cincinnati, Ohio
• Treatment of Advanced Recurrent Metastatic Endometrial Carcinoma with Weekly Topotecan (Hycamtin). 
  Global Hycamtin Clinical Workshop, Hollywood, Florida
• FHCI MD Brings Healing Touch to Central Africa. 
• Overview of Data from a Dose Escalating Trial of Weekly Hycamtin in Recurrent Endometrial Cancer. 
  GlaxoSmithKline Protocol Workshop - Orlando, Florida
• Prevention of Surgical Adhesions in Gynecologic Abdominal Surgery. 
  Charles E. Flowers Society Meeting - Edinburgh, Scotland
• Postsurgical Adhesive Disease: Precaution Strategies for the Abdominal Pelvic Surgeon. 
  Orlando Regional Medical Center
• Introduction of Robotic Surgery in a Gynecologic Oncology Private Practice. 
  Las Vegas, NV, 2008; Tampa, FL, 2008
• Robotic Surgery Applications in Gynecology and Gynecologic Oncology. 
  Ft. Lauderdale, FL, 2008; Melbourne, FL, 2008; Baltimore, MD, 2008; New Orleans, LA , 2008
• Join now to see all

Other

• The Carbon Dioxide Laser- A Guide to Its Use in Lower Genital Tract Disorders, Part I. 
  Holloway RW; Barnes WA; Barter JF
• The Carbon Dioxide Laser- A Guide to Its Use in Lower Genital Tract Disorders, Part II. 
  Holloway RW; Barnes WA; Barter JF, Female Patient 13(7):74-89